Gen. Gustave Perna says as soon as the FDA deems a vaccine safe and effective, his team is ready to coordinate deployment of tens of millions of doses as early as next month.
Pfizer's COVID-19 vaccine is the first to have data showing that it exceeded the minimum effectiveness threshold set by the Food and Drug Administration for emergency use.
NPR's Mary Louise Kelly talks with Gen. Gustave Perna about overseeing the logistics of a coronavirus vaccine for the Trump administration's Operation Warp Speed program.
The Trump administration has been marked by a scaled-back federal investment and involvement in U.S. health care. Biden's team has plans to change that — even if Republicans retain Senate control.
Coronavirus cases are surging around the country. How will Joe Biden manage the pandemic differently, once he takes office in January? Expect a more centralized U.S. response plan, his team says.
Newly released COVID-19 vaccine contracts include weakened protections against potential price gouging. Several key federal contracts still haven't been disclosed by the government.
An unreleased CDC review obtained by NPR shows that lab officials knew an early coronavirus test kit had a high failure rate. They decided not to recall it and sent it to the nation's labs anyway.
To boost the supply of Regeneron's antibody therapy for COVID-19, the federal government entered into a $450 million supply contract. Details of the deal show some safeguards are missing.
A team of independent advisers to the Centers for Disease Control and Prevention has a science-based outline for deploying a vaccine when it's ready. The goal is to stop deaths and viral spread fast.
NPR's Mary Louise Kelly talks with Jose Romero, chair of the Centers for Disease Control and Prevention's immunization committee, about the committee's recommendations for coronavirus vaccination.
In talk of the impact Amy Coney Barrett could have on abortion rights, many people overlook related cases that might be in play, including the right to birth control that the court recognized in 1965.
Drug industry veteran Moncef Slaoui is a key figure in Operation Warp Speed's push to develop COVID-19 coronavirus vaccines. His employment terms raised concerns about potential conflicts of interest.
In advance of a COVID-19 vaccine being available, a group of independent medical advisers to the Centers for Disease Control and Prevention weighed Friday who should get the vaccine first and how.
The federal government plans to distribute 300,000 doses of the drug at no cost, but that doesn't mean treatment will be free. Intravenous infusion charges can run more than $1,000.